Artemis Therapeutics Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced operating income was USD 22,000 compared to USD 203,000 a year ago. Net loss was USD 24,000 compared to USD 108,000 a year ago. Basic eps was USD 0 compared to basic loss per share of USD 0.02 a year ago. For the nine months, operating income was USD 112,000 compared to USD 715,000 a year ago. Net loss was USD 114,000 compared to USD 460,000 a year ago. Basic loss per share was USD 0.02 compared to USD 0.08 a year ago.